|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
2525484 |
003 |
ICU |
005 |
20030522115500.0 |
008 |
961014s1996 nyua b 001 0 eng c |
010 |
|
|
|a 96028774
|
020 |
|
|
|a 0306452553
|
035 |
|
|
|a (ICU)BID22511264
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
041 |
0 |
|
|a eng
|
050 |
0 |
0 |
|a RC607.A26
|b I45 1996
|
060 |
|
0 |
|a WC 503 I33 1996
|
082 |
0 |
0 |
|a 616.97/92079
|2 20
|
245 |
0 |
0 |
|a Immunology of HIV infection /
|c edited by Sudhir Gupta.
|
260 |
|
|
|a New York :
|b Plenum Medical Book Co.,
|c c1996.
|
300 |
|
|
|a xxv, 612 p. :
|b ill. ;
|c 26 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g Ch. 1.
|t Genetic Organization of HIV /
|r Lee Ratner --
|g Ch. 2.
|t T-Cell Epitopes of HIV-1 Envelope Glycoprotein /
|r Christopher B. Buck and Robert F. Siliciano --
|g Ch. 3.
|t B-Cell Sites in the HIV Glycoproteins /
|r Ewa Bjorling and Erling Norrby --
|g Ch. 4.
|t Lymphocyte Adhesion Coreceptors and Their Roles in HIV-1 Replication /
|r Jeffrey A. Ledbetter --
|g Ch. 5.
|t HIV in Lymph Node and Thymus /
|r Dhavalkumar D. Patel, Laura P. Hale and Barton F. Haynes --
|g Ch. 6.
|t Effects of HIV-1 and HIV-1 Envelope Glycoproteins on Signaling Pathways in Human T Lymphocytes /
|r Sudhir Gupta --
|g Ch. 7.
|t Lymphocyte Apoptosis in HIV Infection /
|r Naoki Oyaizu and Savita Pahwa --
|g Ch. 8.
|t Biological Activities of HIV-Specific Peptides /
|r Stanley A. Schwartz, Madhavan P. N. Nair and Linda B. Ludwig --
|g Ch. 9.
|t Phenotype and Function of T Cells in HIV Disease /
|r Janis V. Giorgi --
|g Ch. 10.
|t Cytotoxic T-Lymphocyte Responses to HIV: From Primary Infection to AIDS /
|r Brigitte Autran --
|g Ch. 11.
|t Type 1 and Type 2 Responses in HIV Infection and Exposure /
|r Gene M. Shearer and Mario Clerici --
|g Ch. 12.
|t Humoral Immunity to HIV-1: Lethal Force or Trojan Horse? /
|r Peter L. Nara --
|g Ch. 13.
|t Autoimmunity in HIV /
|r Charles S. Via and Arif R. Sarwari --
|g Ch. 14.
|t Cytokine Cascades in HIV Infection /
|r Guido Poli and Anthony S. Fauci --
|g Ch. 15.
|t Macrophage Functions in HIV-1 Infection /
|r Sharon M. Wahl, Jan M. Orenstein and Phillip D. Smith --
|g Ch. 16.
|t Dendritic Cell Functions in HIV Infection /
|r Stella C. Knight --
|g Ch. 17.
|t Natural Killer Cells in HIV Infection /
|r Benjamin Bonavida and Anahid Jewett --
|g Ch. 18.
|t HIV and Complement /
|r Manfred P. Dierich, Heribert Stoiber and Ying-Hua Chen --
|g Ch. 19.
|t Polymorphonuclear Leukocyte Function in HIV /
|r Shyh-Dar Shyur and Harry R. Hill --
|g Ch. 20.
|t Mucosal Immunity in HIV Infection /
|r Herman F. Staats and Jerry R. McGhee --
|g Ch. 21.
|t The Putative Role of HIV-1 Envelope Proteins in the Neuroimmunology and Neuropathology of CNS AIDS /
|r Prasad Koka and Jean E. Merrill --
|g Ch. 22.
|t Immunopathogenesis of Kaposi's Sarcoma /
|r Felipe Samaniego and Robert C. Gallo --
|g Ch. 23.
|t Pathogenesis of HIV-Associated Lymphoma /
|r Valerie L. Ng and Michael S. McGrath --
|g Ch. 24.
|t The Immunotherapy of HIV Infection with Drugs /
|r John W. Hadden --
|g Ch. 25.
|t Biologic Response Modifiers (Interleukins and Interferons) /
|r Gwendolyn Anne Fyfe and H. Clifford Lane --
|g Ch. 26.
|t Thymic Hormones in the Treatment of AIDS and Other Infectious Diseases /
|r Allan L. Goldstein, Prem S. Sarin and Enrico Garaci --
|g Ch. 27.
|t Growth Factors in the Treatment of HIV Disease /
|r David T. Scadden and David W. Golde --
|g Ch. 28.
|t T-Cell Vaccination for HIV-Seropositive Patients /
|r Henri Atlan and Irun R. Cohen --
|g Ch. 29.
|t HIV Vaccines /
|r Dani P. Bolognesi --
|g Ch. 30.
|t Gene Therapy /
|r Richard A. Morgan.
|
650 |
|
0 |
|a HIV infections
|x Immunological aspects.
|
650 |
1 |
2 |
|a HIV Infections
|x immunology.
|
650 |
2 |
2 |
|a HIV Infections
|x drug therapy.
|
650 |
2 |
2 |
|a Immunotherapy.
|
650 |
|
7 |
|a HIV infections
|x Immunological aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst00949886
|
700 |
1 |
|
|a Gupta, Sudhir.
|0 http://id.loc.gov/authorities/names/n79018225
|1 http://viaf.org/viaf/66540968
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
035 |
|
|
|a (OCoLC)35068160
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 1621006a-a269-5c14-949a-5d0bfcf37a78
|s 3877fcb8-36af-507d-9d4a-a6e8cdc1d772
|
928 |
|
|
|t Library of Congress classification
|a RC607.A26I450 1996
|l JCL
|c JCL-Sci
|i 6048189
|
927 |
|
|
|t Library of Congress classification
|a RC607.A26I450 1996
|l JCL
|c JCL-Sci
|e CRERAR
|b 43590145
|i 4702742
|